$11.428
-0.247 (-2.16%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
INKT Prediction & Forecast by Similar Chart Analysis
Alphio's INKT stock price prediction model matches the current Mink Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.39 (-0.35%). The 1-week path is $11.13 (-2.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Mink Therapeutics Inc Stock?
Mink Therapeutics Inc (INKT) is currently not a strong buy due to its recent performance and financial metrics. The stock is trading at $11.43, and the RSI is at 46.944, indicating a neutral momentum. The company reported a net loss of $3.1 million in Q2 2026, which is significant, and the forward P/E ratio is currently 0, reflecting uncertainty in future earnings. Additionally, insider selling has increased by 432.67% over the last month, which raises concerns about insider confidence in the stock's future performance. The main risk is the ongoing negative earnings trend, with EPS reported at -0.62 for Q2 2026, suggesting continued financial challenges. Overall, while there are some positive developments in clinical trials, the financial instability and insider selling suggest a cautious approach for long-term investors.
INKT stock price ended at $11.43 on Friday, after losing -2.16%
Mink Therapeutics Inc (INKT) last closed at $11.4282, losing -2.16%. These facts feed the 1-day and 1-week INKT price prediction above.
Forecast Drivers
Mink Therapeutics Inc (INKT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches INKT, ranked by similarity.
Seasonality analysis for INKT
Historically the probability of a positive August return for INKT is 56.25%. August offers the highest probability of a positive month at 56.25%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for INKT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $16.65 | $18.92 | $20.70 | +65.55% |
| Sep 2026 | $20.79 | $24.52 | $27.77 | +114.59% |
| Oct 2026 | $21.49 | $22.55 | $24.49 | +97.31% |
| Nov 2026 | $17.71 | $21.48 | $22.71 | +87.95% |
| Dec 2026 | $20.18 | $23.51 | $27.18 | +105.71% |
In 2026, Mink Therapeutics Inc (INKT) is projected to range from $16.65 to $27.77.
Mink Therapeutics Inc 2026 monthly forecast
In Aug 2026, Mink Therapeutics Inc is projected to average $18.92, with a low of $16.65 and high of $20.70.
In Sep 2026, Mink Therapeutics Inc is projected to average $24.52, with a low of $20.79 and high of $27.77.
In Oct 2026, Mink Therapeutics Inc is projected to average $22.55, with a low of $21.49 and high of $24.49.
In Nov 2026, Mink Therapeutics Inc is projected to average $21.48, with a low of $17.71 and high of $22.71.
In Dec 2026, Mink Therapeutics Inc is projected to average $23.51, with a low of $20.18 and high of $27.18.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.